Navigation Links
CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
Date:1/15/2008

presentation.

About CryoCor

CryoCor is a medical technology company that has developed and manufactures a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The Company's product, the CryoCor Cardiac Cryoablation System, or the Cryoablation System, is designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The Cryoablation System has been approved in Europe for the treatment of atrial fibrillation, and atrial flutter, the two most common and difficult to treat arrhythmias, since 2002. In the United States, CryoCor is conducting a pivotal trial to evaluate the safety and efficacy of the Cryoablation System for the treatment of atrial fibrillation and the Cryoablation System has been approved for the treatment of right atrial flutter. For more information please visit the Company's website at http://www.cryocor.com

Forward Looking Statements

The statements in this press release that are not descriptions of historical facts are forward-looking statements that are subject to risks and uncertainties. These include statements related to the advantages and benefits provided by the Company's technology and the timing for when the Company expects to enter human trials with Quantum. Such statements are only predictions and reflect CryoCor's expectations and assumptions as of the date of this press release based on currently available operating, financial, and competitive information. The actual events or results may differ materially from those projected in such forward-looking statements due to a number of factors, including risks involved with CryoCor's technology, its development and the Company's anticipated timetable for developing and evaluating its technology; risks involved with the diagnosis and treatment of atrial arrhythmias; risks associ
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. CryoCor to Present at CIBC World Markets 18th Annual Healthcare Conference
2. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
3. Highlights of Economic and Business Growth in the Tampa Bay Region
4. Highlights of Economic and Business Growth in the Tampa Bay Region
5. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
6. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
7. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
8. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
9. Highlights of Economic and Business Growth in the Tampa Bay Region
10. Access Highlighted in Recent BusinessWeek Article
11. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Interventional cardiologist Tony Farah, MD, and his ... Cardiovascular Institute have helped pioneer many breakthroughs in ... over the past three decades, from new disease-fighting medications ... artery stent implantation. , Today, AGH officials announced that ... in the study of a novel, first-of-its kind investigational ...
(Date:5/20/2013)... 20, 2013 Kitware, a leader in ... that enables the exploration of hospital costs across ... response to the recent release of “Medicare Provider Charge ... 100 most-billed procedures from the Centers for Medicare & ... similar procedures at hospitals across the country has sparked ...
(Date:5/19/2013)... The JM Internet Group (web: jm-seo.org), a leader ... that the company's YouTube channel on SEO tips ... YouTube. The company uses YouTube as a way to ... for small businesses with much success. , "I love ... for their SEO strategies", explained Jason McDonald, director of ...
(Date:5/17/2013)... occurs when the transplant recipient,s immune system identifies the ... was previously thought that T cells, the immune cells ... known as chemokines in order to migrate to the ... of Clinical Investigation , Fadi Lakkis and colleagues at ... chemokine stimulation of T cells is not required for ...
Breaking Biology Technology:Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4Kitware Enables Interactive Exploration of CMS Medicare Data 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2
... Lilly and Company,strongly objects to implications in a New ... results of negative clinical,trials., The story, based on ... (NEJM), cited Prozac and Lilly as high-profile examples of ... only was,the Times, story inaccurate when it comes to ...
... Collected on myLifetime.com in ... Protection Act Allows Women Choice to, Recuperate for at Least 48 ... ... -, NEW YORK, Jan. 18 "Desperate Housewives",star Marcia Cross will ...
... Corporation today,announced the appointment of Wendy Perrow, as ... Ms. Perrow will be responsible for,leading Alba,s marketing ... commercialization. Ms. Perrow will also serve as a,member ... are very pleased to announce that Ms. Perrow ...
Cached Biology Technology:In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 2In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 4Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference 2Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference 3Alba Therapeutics Appoints Wendy Perrow as its Vice President, Marketing and Alliance Management 2
(Date:5/18/2013)... 18, 2013) An increasing number of U.S. ... to resolve, according to research presented at Digestive ... targeting obesity, researchers at the Cleveland Clinic Children,s ... pattern of exhaled breath compared to their lean ... compound levels that can be correlated to potential ...
(Date:5/17/2013)... group of proteins in the brain responsible for protecting ... that could increase cell survival. , The discovery, made ... published in the EMBO journal with additional ... therapies for stroke and other brain diseases. , The ... identified a protein, known as SUMO, responsible for controlling ...
(Date:5/17/2013)... An international team of scientists using a new X-ray ... a living frog embryo in greater detail than ever ... biological research and the search for new treatments for ... Institut fr Technologie in Germany, in collaboration with the ... Argonne National Laboratory, released the most precise depiction ever ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3SUMO wrestling cells reveal new protective mechanism target for stroke 2New X-ray method shows how frog embryos could help thwart disease 2
... Delbrck Center for Molecular Medicine (MDC) Berlin-Buch have discovered ... cell types and thus to be pluripotent. This pluripotency ... primarily known for its role in mediating cell-cell adhesion ... absent, the stem cells lose their pluripotency. The molecule ...
... A bacteria which infects people with cystic fibrosis ... team from Cardiff and Warwick Universities. Continuous use ... causing major health problems all over the world. New ... multidrug-resistant bacteria such as the MRSA superbug. ...
... Results of a study, involving 98,454 patients demonstrated that ... patients were approximately 20% less likely to be prescribed ... to healthy patients. These finding remained relatively unchanged at ... with a high number being prescribed the current standards ...
Cached Biology News:MDC researchers discover key molecule for stem cell pluripotency 2Cystic fibrosis bacteria could help fight back against antibiotic resistance 2Undertreatment of cardiovascular disease in rheumatoid arthritis patients following a heart attack 2
Required to perform reference file generation, flatfield calibration and performance verification processes on the GSD-501...
... TempliPhi 100 Amplification Kit, 100 reactions. ... sequencing in 4-6 h.Generate microgram quantities ... of starting material.Use amplified DNA directly ... from bacterial or M13 liquid cultures, ...
... Rack inserts fit into the ... allow you to greatly increase ... deepwell format plates at an ... from the shaker at once ...
BD FastImmune EDTA Solution. Applications: Flow Cytometry Storage Temperature: Refrigerate(2 to 8C)...
Biology Products: